Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry landscape, 2018 - 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Surging demand for pet insurance policies worldwide
3.2.1.2 Rising rate of obesity in companion animals
3.2.1.3 Increasing government support for pet care across the globe
3.2.1.4 Growing demand for online veterinary pharmacies
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with companion animal drugs
3.3 Growth potential analysis
3.4 Regulatory landscape/policy landscape
3.4.1 U.S.
3.4.2 Europe
3.4.3 Asia-Pacific
3.5 Gap analysis
3.6 Consumer behavior trends
3.7 Industry ecosystem
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.1.1 Zoetis Inc.
4.1.2 Boehringer Ingelheim International GmbH
4.1.3 Elanco Animal Health Incorporated
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Drugs
5.2.1 Antiparasitic
5.2.2 Anti-inflammatory
5.2.3 Anti-infectives
5.2.4 Corticosteroids
5.2.5 Tranquilizers
5.2.6 Cardiovascular drugs
5.2.7 Gastrointestinal drugs
5.3 Vaccines
5.3.1 Modified live vaccines (MLV)
5.3.2 Killed inactivated vaccines
5.3.3 Recombinant vaccines
5.4 Medicated feed additives
5.4.1 Antibiotics
5.4.2 Vitamins
5.4.3 Amino acids
5.4.4 Enzymes
5.4.5 Antioxidants
5.4.6 Prebiotics and probiotics
5.4.7 Minerals
5.4.8 Carbohydrates
5.4.9 Propandiol
Chapter 6 Market Estimates and Forecast, By Animal Type, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Dogs
6.3 Cats
6.4 Horses
6.5 Other animals
Chapter 7 Market Estimates and Forecast, By Route of Administration, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Oral
7.3 Injectable
7.4 Topical
7.5 Other routes of administration
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Veterinary hospital pharmacy
8.3 Retail pharmacy
8.4 E-commerce
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 Netherlands
9.3.8 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Taiwan
9.4.7 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 GCC Countries
9.6.3 Israel
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Agrolabo S.p.A.
10.2 Boehringer Ingelheim International GmbH
10.3 Ceva Santé Animale
10.4 Chanelle Pharma
10.5 Dechra Pharmaceuticals PLC
10.6 Elanco Animal Health Incorporated
10.7 Endovac Animal Health
10.8 HIPRA
10.9 Indian Immunologicals Ltd.
10.10 Merck & Co., Inc.
10.11 Norbrook
10.12 Symrise
10.13 Vetoquinol
10.14 Virbac
10.15 Zoetis Inc.
